What Do Biotech IPOs Say About the Market Today?
2015 started out strong for biotech IPOs, but in recent weeks there's been a slowdown.
2015 started out strong for biotech IPOs, but in recent weeks there's been a slowdown.
The NASDAQ Biotechnology Index is falling, following media criticism about the industry's pricing practises. The Trans-Pacific...
Everything that investors need to know about decreasing risk through diversification in the biotech sector.
The company's announcement points to a larger trend towards biotech innovation in the San Diego area.
Apricus hopes that the FDA's approval of Addyi, a drug from Sprout Pharmaceuticals, will offer a...
The contract, valued at approximately $143.5 million, will support the development of Pfenex's mutant recombinant protective...
Global Blood Therapeutics began trading on the NASDAQ on Wednesday. The company raised $120 million in...